nodes	percent_of_prediction	percent_of_DWPC	metapath
Tripelennamine—Bepridil—hypertension	0.456	1	CrCtD
Tripelennamine—Aprindine—Quinapril—hypertension	0.0399	0.144	CrCrCtD
Tripelennamine—Mepyramine—Diltiazem—hypertension	0.0372	0.134	CrCrCtD
Tripelennamine—Alverine—Bepridil—hypertension	0.0272	0.0983	CrCrCtD
Tripelennamine—Antazoline—Bepridil—hypertension	0.0235	0.0849	CrCrCtD
Tripelennamine—Dextropropoxyphene—Bepridil—hypertension	0.0187	0.0675	CrCrCtD
Tripelennamine—Phenoxybenzamine—Bepridil—hypertension	0.0187	0.0675	CrCrCtD
Tripelennamine—CYP2D6—Nebivolol—hypertension	0.0183	0.079	CbGbCtD
Tripelennamine—CYP2D6—Labetalol—hypertension	0.0183	0.079	CbGbCtD
Tripelennamine—Dextropropoxyphene—Quinapril—hypertension	0.0182	0.0657	CrCrCtD
Tripelennamine—Dimetacrine—Diltiazem—hypertension	0.0171	0.0617	CrCrCtD
Tripelennamine—CYP2D6—Acebutolol—hypertension	0.0168	0.0723	CbGbCtD
Tripelennamine—CYP2D6—Metoprolol—hypertension	0.0156	0.0672	CbGbCtD
Tripelennamine—CYP2D6—Pindolol—hypertension	0.0156	0.0672	CbGbCtD
Tripelennamine—Imipramine—Benazepril—hypertension	0.0152	0.0548	CrCrCtD
Tripelennamine—CYP2D6—Betaxolol—hypertension	0.0139	0.0599	CbGbCtD
Tripelennamine—Benzphetamine—Bepridil—hypertension	0.0131	0.0472	CrCrCtD
Tripelennamine—Promazine—Diltiazem—hypertension	0.0128	0.0463	CrCrCtD
Tripelennamine—CYP2D6—Doxazosin—hypertension	0.0122	0.0527	CbGbCtD
Tripelennamine—Benzyl Benzoate—Bepridil—hypertension	0.0121	0.0437	CrCrCtD
Tripelennamine—CYP2D6—Diltiazem—hypertension	0.0118	0.0509	CbGbCtD
Tripelennamine—Diphenhydramine—Bepridil—hypertension	0.0116	0.0419	CrCrCtD
Tripelennamine—Benzyl Benzoate—Benazepril—hypertension	0.0115	0.0416	CrCrCtD
Tripelennamine—CYP2D6—Bepridil—hypertension	0.0105	0.0454	CbGbCtD
Tripelennamine—CYP2D6—Irbesartan—hypertension	0.00964	0.0415	CbGbCtD
Tripelennamine—CYP2D6—Amlodipine—hypertension	0.00945	0.0407	CbGbCtD
Tripelennamine—CYP2D6—Felodipine—hypertension	0.00911	0.0392	CbGbCtD
Tripelennamine—CYP2D6—Timolol—hypertension	0.00896	0.0386	CbGbCtD
Tripelennamine—CYP2D6—Nifedipine—hypertension	0.00881	0.038	CbGbCtD
Tripelennamine—CYP2D6—Nicardipine—hypertension	0.00868	0.0374	CbGbCtD
Tripelennamine—CYP2D6—Carvedilol—hypertension	0.00868	0.0374	CbGbCtD
Tripelennamine—CYP2D6—Propranolol—hypertension	0.00799	0.0344	CbGbCtD
Tripelennamine—CYP2D6—Captopril—hypertension	0.00789	0.034	CbGbCtD
Tripelennamine—CYP2D6—Clonidine—hypertension	0.00762	0.0328	CbGbCtD
Tripelennamine—CYP2D6—Atorvastatin—hypertension	0.00679	0.0292	CbGbCtD
Tripelennamine—CYP2D6—Verapamil—hypertension	0.00548	0.0236	CbGbCtD
Tripelennamine—Chloropyramine—PTK2—hypertension	0.000373	0.118	CrCbGaD
Tripelennamine—Aprindine—CALM2—hypertension	0.000209	0.0661	CrCbGaD
Tripelennamine—Bepridil—KCNQ1—hypertension	0.000175	0.0552	CrCbGaD
Tripelennamine—Aprindine—CALM1—hypertension	0.000135	0.0426	CrCbGaD
Tripelennamine—Bepridil—CALM2—hypertension	0.000129	0.0408	CrCbGaD
Tripelennamine—Bepridil—ATP1A1—hypertension	0.000106	0.0334	CrCbGaD
Tripelennamine—Phenoxybenzamine—CALM2—hypertension	0.000101	0.0318	CrCbGaD
Tripelennamine—Captodiame—DRD3—hypertension	8.83e-05	0.0279	CrCbGaD
Tripelennamine—Bepridil—CALM1—hypertension	8.33e-05	0.0263	CrCbGaD
Tripelennamine—Chlorphenamine—SLC6A2—hypertension	7.28e-05	0.023	CrCbGaD
Tripelennamine—Rosiglitazone—PPARG—hypertension	7.25e-05	0.0229	CrCbGaD
Tripelennamine—Phenoxybenzamine—ADRA2B—hypertension	6.71e-05	0.0212	CrCbGaD
Tripelennamine—Phenoxybenzamine—CALM1—hypertension	6.49e-05	0.0205	CrCbGaD
Tripelennamine—Benzphetamine—SLC6A2—hypertension	6.16e-05	0.0195	CrCbGaD
Tripelennamine—Doxepin—ADRA2B—hypertension	5.46e-05	0.0172	CrCbGaD
Tripelennamine—Rosiglitazone—PTGS1—hypertension	5.35e-05	0.0169	CrCbGaD
Tripelennamine—Doxepin—SLC6A2—hypertension	4.79e-05	0.0151	CrCbGaD
Tripelennamine—Orphenadrine—SLC6A2—hypertension	4.67e-05	0.0147	CrCbGaD
Tripelennamine—Doxepin—HTR2B—hypertension	4.5e-05	0.0142	CrCbGaD
Tripelennamine—Benzphetamine—ADRA1A—hypertension	4.34e-05	0.0137	CrCbGaD
Tripelennamine—Phenoxybenzamine—ADRA1A—hypertension	4.15e-05	0.0131	CrCbGaD
Tripelennamine—Diphenhydramine—CYP2C18—hypertension	3.97e-05	0.0125	CrCbGaD
Tripelennamine—Chlorphenamine—CYP3A5—hypertension	3.86e-05	0.0122	CrCbGaD
Tripelennamine—Methadone—CYP2C18—hypertension	3.83e-05	0.0121	CrCbGaD
Tripelennamine—Imipramine—SLC6A2—hypertension	3.73e-05	0.0118	CrCbGaD
Tripelennamine—Amitriptyline—SLC6A2—hypertension	3.71e-05	0.0117	CrCbGaD
Tripelennamine—Chlorphenamine—SLC6A3—hypertension	3.7e-05	0.0117	CrCbGaD
Tripelennamine—Tamoxifen—ESR2—hypertension	3.51e-05	0.0111	CrCbGaD
Tripelennamine—Doxepin—ADRA1A—hypertension	3.38e-05	0.0107	CrCbGaD
Tripelennamine—Benzphetamine—SLC6A3—hypertension	3.14e-05	0.0099	CrCbGaD
Tripelennamine—Benzphetamine—ADRA2A—hypertension	3.07e-05	0.00971	CrCbGaD
Tripelennamine—Cyclobenzaprine—HTR2A—hypertension	3.04e-05	0.00961	CrCbGaD
Tripelennamine—Promazine—ADRA1A—hypertension	3e-05	0.00948	CrCbGaD
Tripelennamine—Imipramine—CYP2C18—hypertension	3e-05	0.00947	CrCbGaD
Tripelennamine—Phenoxybenzamine—ADRA2A—hypertension	2.94e-05	0.00928	CrCbGaD
Tripelennamine—Chlorphenamine—SLC6A4—hypertension	2.77e-05	0.00874	CrCbGaD
Tripelennamine—Rosiglitazone—ALB—hypertension	2.73e-05	0.00861	CrCbGaD
Tripelennamine—Imipramine—ADRA1A—hypertension	2.63e-05	0.0083	CrCbGaD
Tripelennamine—Amitriptyline—ADRA1A—hypertension	2.61e-05	0.00825	CrCbGaD
Tripelennamine—Tamoxifen—CYP3A5—hypertension	2.55e-05	0.00805	CrCbGaD
Tripelennamine—Methadone—CYP3A5—hypertension	2.53e-05	0.00798	CrCbGaD
Tripelennamine—Phenoxybenzamine—ADRB2—hypertension	2.47e-05	0.00779	CrCbGaD
Tripelennamine—Doxepin—ADRA2A—hypertension	2.39e-05	0.00755	CrCbGaD
Tripelennamine—Tamoxifen—CYP19A1—hypertension	2.35e-05	0.00741	CrCbGaD
Tripelennamine—Methadone—CYP19A1—hypertension	2.33e-05	0.00735	CrCbGaD
Tripelennamine—Imipramine—HTR7—hypertension	2.17e-05	0.00685	CrCbGaD
Tripelennamine—Amitriptyline—HTR7—hypertension	2.16e-05	0.00681	CrCbGaD
Tripelennamine—Promazine—ADRA2A—hypertension	2.12e-05	0.00671	CrCbGaD
Tripelennamine—Amitriptyline—HTR1B—hypertension	2.09e-05	0.00659	CrCbGaD
Tripelennamine—Amitriptyline—DRD3—hypertension	2.03e-05	0.0064	CrCbGaD
Tripelennamine—Amitriptyline—CYP3A5—hypertension	1.96e-05	0.0062	CrCbGaD
Tripelennamine—Diphenhydramine—PTGS1—hypertension	1.94e-05	0.00613	CrCbGaD
Tripelennamine—Imipramine—SLC6A3—hypertension	1.9e-05	0.00599	CrCbGaD
Tripelennamine—Amitriptyline—ADRA2A—hypertension	1.85e-05	0.00584	CrCbGaD
Tripelennamine—Doxepin—SLC6A4—hypertension	1.82e-05	0.00576	CrCbGaD
Tripelennamine—Doxepin—DRD2—hypertension	1.81e-05	0.00573	CrCbGaD
Tripelennamine—Tamoxifen—CYP1A1—hypertension	1.73e-05	0.00546	CrCbGaD
Tripelennamine—Promazine—DRD2—hypertension	1.61e-05	0.00509	CrCbGaD
Tripelennamine—Imipramine—SLC6A4—hypertension	1.42e-05	0.00448	CrCbGaD
Tripelennamine—Imipramine—DRD2—hypertension	1.41e-05	0.00446	CrCbGaD
Tripelennamine—Amitriptyline—SLC6A4—hypertension	1.41e-05	0.00445	CrCbGaD
Tripelennamine—Amitriptyline—DRD2—hypertension	1.4e-05	0.00443	CrCbGaD
Tripelennamine—Doxepin—HTR2A—hypertension	1.4e-05	0.00443	CrCbGaD
Tripelennamine—Promazine—HTR2A—hypertension	1.25e-05	0.00393	CrCbGaD
Tripelennamine—Imipramine—HTR2A—hypertension	1.09e-05	0.00344	CrCbGaD
Tripelennamine—Amitriptyline—HTR2A—hypertension	1.08e-05	0.00342	CrCbGaD
Tripelennamine—HRH1—Signaling by GPCR—VAV3—hypertension	8.9e-06	0.000279	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HSPG2—hypertension	8.9e-06	0.000279	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PRKG1—hypertension	8.82e-06	0.000277	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ADM—hypertension	8.82e-06	0.000277	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PTH—hypertension	8.82e-06	0.000277	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GABBR1—hypertension	8.82e-06	0.000277	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PDE4D—hypertension	8.82e-06	0.000277	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—GNB3—hypertension	8.69e-06	0.000273	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYP4A11—hypertension	8.66e-06	0.000272	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CBS—hypertension	8.66e-06	0.000272	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ARG2—hypertension	8.66e-06	0.000272	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CYBB—hypertension	8.59e-06	0.00027	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GLP1R—hypertension	8.59e-06	0.00027	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TACR1—hypertension	8.59e-06	0.00027	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—CXCL8—hypertension	8.59e-06	0.00027	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—AVP—hypertension	8.57e-06	0.000269	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hypertension	8.55e-06	0.000269	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—ADCY5—hypertension	8.53e-06	0.000268	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—XDH—hypertension	8.5e-06	0.000267	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—PRKCG—hypertension	8.47e-06	0.000266	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—GNAS—hypertension	8.46e-06	0.000266	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HRH3—hypertension	8.45e-06	0.000265	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—PRKCA—hypertension	8.41e-06	0.000264	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SLC5A2—hypertension	8.34e-06	0.000262	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYP3A5—hypertension	8.34e-06	0.000262	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PTGIS—hypertension	8.34e-06	0.000262	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—EDN1—hypertension	8.15e-06	0.000256	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CCL5—hypertension	8.09e-06	0.000254	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HSD11B1—hypertension	8.06e-06	0.000253	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ABCC1—hypertension	8.06e-06	0.000253	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—UCP2—hypertension	8.06e-06	0.000253	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—UCP3—hypertension	8.06e-06	0.000253	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—TPH1—hypertension	8.06e-06	0.000253	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CCR5—hypertension	8.03e-06	0.000252	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—PRKCD—hypertension	8.03e-06	0.000252	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NCF2—hypertension	7.86e-06	0.000247	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—HTR2A—hypertension	7.85e-06	0.000247	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—C3—hypertension	7.84e-06	0.000246	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ALAS1—hypertension	7.8e-06	0.000245	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SLC2A3—hypertension	7.8e-06	0.000245	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYP11B2—hypertension	7.8e-06	0.000245	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—ADCY5—hypertension	7.74e-06	0.000243	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PRKCG—hypertension	7.69e-06	0.000241	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ADA—hypertension	7.68e-06	0.000241	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HSD3B1—hypertension	7.68e-06	0.000241	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—VWF—hypertension	7.66e-06	0.00024	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NPY—hypertension	7.66e-06	0.00024	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PRKCA—hypertension	7.64e-06	0.00024	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—FADS1—hypertension	7.57e-06	0.000238	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—AQP1—hypertension	7.57e-06	0.000238	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—AGT—hypertension	7.45e-06	0.000234	CbGpPWpGaD
Tripelennamine—Amitriptyline—ALB—hypertension	7.42e-06	0.00234	CrCbGaD
Tripelennamine—HRH1—Signaling Pathways—AGTR2—hypertension	7.39e-06	0.000232	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HTR1B—hypertension	7.39e-06	0.000232	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—OXT—hypertension	7.39e-06	0.000232	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CXCL2—hypertension	7.39e-06	0.000232	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CA9—hypertension	7.37e-06	0.000231	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—TBXAS1—hypertension	7.37e-06	0.000231	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TGFBR1—hypertension	7.31e-06	0.000229	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—F2R—hypertension	7.31e-06	0.000229	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CCR5—hypertension	7.29e-06	0.000229	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PRKCD—hypertension	7.29e-06	0.000229	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ALOX5AP—hypertension	7.18e-06	0.000225	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ALOX15—hypertension	7.18e-06	0.000225	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—HTR2A—hypertension	7.13e-06	0.000224	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—C3—hypertension	7.12e-06	0.000224	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NCF1—hypertension	7.08e-06	0.000222	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—EDNRB—hypertension	7.08e-06	0.000222	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HADHA—hypertension	7.01e-06	0.00022	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—LHB—hypertension	7.01e-06	0.00022	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TAC1—hypertension	7e-06	0.00022	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—PRKCB—hypertension	6.89e-06	0.000216	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—F2—hypertension	6.89e-06	0.000216	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ANXA1—hypertension	6.87e-06	0.000216	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CXCR3—hypertension	6.87e-06	0.000216	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—KCNJ11—hypertension	6.85e-06	0.000215	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HSD3B2—hypertension	6.85e-06	0.000215	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—LPA—hypertension	6.85e-06	0.000215	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—IKBKB—hypertension	6.8e-06	0.000214	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—AGT—hypertension	6.77e-06	0.000212	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SST—hypertension	6.68e-06	0.00021	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—EDNRA—hypertension	6.68e-06	0.00021	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CALM1—hypertension	6.65e-06	0.000209	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—FLT1—hypertension	6.65e-06	0.000209	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CYBA—hypertension	6.65e-06	0.000209	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ADRB1—hypertension	6.65e-06	0.000209	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—DRD3—hypertension	6.65e-06	0.000209	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—LRP2—hypertension	6.57e-06	0.000206	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYP2C18—hypertension	6.57e-06	0.000206	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ADRA2A—hypertension	6.54e-06	0.000205	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GHRL—hypertension	6.51e-06	0.000204	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PLAT—hypertension	6.51e-06	0.000204	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CALCA—hypertension	6.43e-06	0.000202	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HSPG2—hypertension	6.32e-06	0.000198	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—BDKRB2—hypertension	6.28e-06	0.000197	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—POMC—hypertension	6.27e-06	0.000197	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—F2—hypertension	6.25e-06	0.000196	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PRKCB—hypertension	6.25e-06	0.000196	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ADRBK1—hypertension	6.21e-06	0.000195	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CNR1—hypertension	6.17e-06	0.000194	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ALOX5—hypertension	6.1e-06	0.000192	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GLP1R—hypertension	6.1e-06	0.000192	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CALM2—hypertension	6.1e-06	0.000191	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—AKT2—hypertension	6.03e-06	0.000189	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—DRD2—hypertension	6.02e-06	0.000189	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HTR7—hypertension	6.02e-06	0.000189	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PTPN1—hypertension	5.96e-06	0.000187	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GCG—hypertension	5.96e-06	0.000187	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NOTCH2—hypertension	5.84e-06	0.000183	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—KL—hypertension	5.84e-06	0.000183	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NGFR—hypertension	5.73e-06	0.00018	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ITGAV—hypertension	5.73e-06	0.00018	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—KNG1—hypertension	5.72e-06	0.000179	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—POMC—hypertension	5.7e-06	0.000179	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PRL—hypertension	5.68e-06	0.000178	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AGTR1—hypertension	5.68e-06	0.000178	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HDAC1—hypertension	5.6e-06	0.000176	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—STK11—hypertension	5.6e-06	0.000176	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ALDH2—hypertension	5.58e-06	0.000175	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CCL2—hypertension	5.57e-06	0.000175	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CXCL10—hypertension	5.55e-06	0.000174	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PLG—hypertension	5.54e-06	0.000174	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—RHOA—hypertension	5.53e-06	0.000174	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—AKT2—hypertension	5.48e-06	0.000172	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—PIK3R1—hypertension	5.47e-06	0.000172	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HBA1—hypertension	5.44e-06	0.000171	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYP11A1—hypertension	5.41e-06	0.00017	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ADRB2—hypertension	5.39e-06	0.000169	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PRKCE—hypertension	5.32e-06	0.000167	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SLC9A1—hypertension	5.31e-06	0.000167	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GSTT1—hypertension	5.31e-06	0.000167	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PDGFA—hypertension	5.26e-06	0.000165	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—VAV3—hypertension	5.26e-06	0.000165	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GCLC—hypertension	5.25e-06	0.000165	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CETP—hypertension	5.25e-06	0.000165	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TGFBR2—hypertension	5.18e-06	0.000163	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GNB3—hypertension	5.13e-06	0.000161	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AVP—hypertension	5.06e-06	0.000159	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYP17A1—hypertension	5.03e-06	0.000158	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—RHOA—hypertension	5.02e-06	0.000158	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GNAS—hypertension	5e-06	0.000157	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ENO1—hypertension	4.98e-06	0.000156	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PTGS1—hypertension	4.98e-06	0.000156	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PIK3R1—hypertension	4.97e-06	0.000156	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—APOB—hypertension	4.89e-06	0.000154	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PTK2—hypertension	4.87e-06	0.000153	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CXCL8—hypertension	4.85e-06	0.000152	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—EDN1—hypertension	4.82e-06	0.000151	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CTGF—hypertension	4.79e-06	0.00015	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CCL5—hypertension	4.78e-06	0.00015	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HMGCR—hypertension	4.75e-06	0.000149	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GOT2—hypertension	4.75e-06	0.000149	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—LPL—hypertension	4.67e-06	0.000147	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ADRA2A—hypertension	4.65e-06	0.000146	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—H2AFX—hypertension	4.64e-06	0.000146	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PDGFRB—hypertension	4.63e-06	0.000145	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—RPS6KB1—hypertension	4.63e-06	0.000145	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ADCY5—hypertension	4.58e-06	0.000144	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PRKCG—hypertension	4.54e-06	0.000143	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PRKCA—hypertension	4.51e-06	0.000142	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ITGB3—hypertension	4.51e-06	0.000142	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—YWHAZ—hypertension	4.48e-06	0.000141	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NGF—hypertension	4.43e-06	0.000139	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SPP1—hypertension	4.43e-06	0.000139	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CXCL8—hypertension	4.41e-06	0.000138	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—TH—hypertension	4.35e-06	0.000137	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CALM2—hypertension	4.33e-06	0.000136	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PRKCD—hypertension	4.31e-06	0.000135	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CCR5—hypertension	4.31e-06	0.000135	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GCG—hypertension	4.23e-06	0.000133	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SLC2A4—hypertension	4.23e-06	0.000133	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HTR2A—hypertension	4.21e-06	0.000132	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—C3—hypertension	4.21e-06	0.000132	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GOT1—hypertension	4.1e-06	0.000129	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PDGFB—hypertension	4.1e-06	0.000129	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—FGFR1—hypertension	4.07e-06	0.000128	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HIF1A—hypertension	4.01e-06	0.000126	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AGT—hypertension	4e-06	0.000125	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—STK11—hypertension	3.98e-06	0.000125	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYP19A1—hypertension	3.98e-06	0.000125	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CALM1—hypertension	3.93e-06	0.000123	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—APOE—hypertension	3.92e-06	0.000123	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—LEP—hypertension	3.92e-06	0.000123	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CAV1—hypertension	3.88e-06	0.000122	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—APOA1—hypertension	3.87e-06	0.000122	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—KDR—hypertension	3.84e-06	0.00012	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—COMT—hypertension	3.7e-06	0.000116	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—FN1—hypertension	3.69e-06	0.000116	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—F2—hypertension	3.69e-06	0.000116	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PRKCB—hypertension	3.69e-06	0.000116	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GNB3—hypertension	3.65e-06	0.000114	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PPARGC1A—hypertension	3.65e-06	0.000114	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HMOX1—hypertension	3.63e-06	0.000114	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NOTCH1—hypertension	3.62e-06	0.000113	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CAT—hypertension	3.58e-06	0.000112	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GNAS—hypertension	3.55e-06	0.000111	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—APOB—hypertension	3.48e-06	0.000109	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GSTM1—hypertension	3.38e-06	0.000106	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—POMC—hypertension	3.37e-06	0.000106	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—INS—hypertension	3.35e-06	0.000105	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—LPL—hypertension	3.32e-06	0.000104	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CCL2—hypertension	3.29e-06	0.000103	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ADCY5—hypertension	3.25e-06	0.000102	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GPX1—hypertension	3.24e-06	0.000102	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—IGF1—hypertension	3.24e-06	0.000102	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AKT2—hypertension	3.23e-06	0.000102	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—EGFR—hypertension	3.22e-06	0.000101	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PRKCA—hypertension	3.21e-06	0.000101	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYP1A1—hypertension	3.21e-06	0.000101	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CD36—hypertension	3.15e-06	9.9e-05	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SERPINE1—hypertension	3.07e-06	9.65e-05	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—MTHFR—hypertension	2.99e-06	9.38e-05	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—FGF2—hypertension	2.98e-06	9.34e-05	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—RHOA—hypertension	2.97e-06	9.31e-05	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PIK3R1—hypertension	2.93e-06	9.21e-05	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NOS3—hypertension	2.93e-06	9.21e-05	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PPARA—hypertension	2.93e-06	9.21e-05	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—AGT—hypertension	2.84e-06	8.92e-05	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CALM1—hypertension	2.79e-06	8.77e-05	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—APOE—hypertension	2.78e-06	8.74e-05	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—RELA—hypertension	2.76e-06	8.67e-05	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CAV1—hypertension	2.76e-06	8.66e-05	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—APOA1—hypertension	2.75e-06	8.64e-05	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MTOR—hypertension	2.71e-06	8.5e-05	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CXCL8—hypertension	2.6e-06	8.17e-05	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—AKT1—hypertension	2.51e-06	7.89e-05	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—IL6—hypertension	2.48e-06	7.77e-05	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PPARG—hypertension	2.42e-06	7.61e-05	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—POMC—hypertension	2.39e-06	7.51e-05	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—INS—hypertension	2.38e-06	7.46e-05	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MMP9—hypertension	2.35e-06	7.39e-05	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CDKN1A—hypertension	2.35e-06	7.36e-05	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PTEN—hypertension	2.34e-06	7.35e-05	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MAPK8—hypertension	2.29e-06	7.19e-05	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—AKT1—hypertension	2.28e-06	7.17e-05	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—EP300—hypertension	2.23e-06	7.01e-05	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ALB—hypertension	2.18e-06	6.84e-05	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SRC—hypertension	2.17e-06	6.81e-05	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—VEGFA—hypertension	2.11e-06	6.64e-05	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PIK3R1—hypertension	2.09e-06	6.55e-05	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—NOS3—hypertension	2.09e-06	6.55e-05	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MYC—hypertension	1.95e-06	6.11e-05	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TGFB1—hypertension	1.94e-06	6.09e-05	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PTGS2—hypertension	1.91e-06	5.99e-05	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—EGFR—hypertension	1.9e-06	5.97e-05	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PTEN—hypertension	1.66e-06	5.22e-05	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TP53—hypertension	1.6e-06	5.01e-05	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—EP300—hypertension	1.59e-06	4.98e-05	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—IL6—hypertension	1.46e-06	4.59e-05	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AKT1—hypertension	1.35e-06	4.23e-05	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—AKT1—hypertension	9.58e-07	3.01e-05	CbGpPWpGaD
